RecruitingNCT04706754
Pan-Canadian Lung Cancer Observational Study (PALEOS)
Sponsor
William Osler Health System
Enrollment
25,000 participants
Start Date
Apr 7, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
A multicenter, ambispective observational study focusing on patients diagnosed with lung cancer in Canada identified after January 1, 2000 inclusive. This data will be combined with that from deceased patients identified.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- • Adults aged 18 years or older having a documented lung cancer diagnosis since 2000.
Exclusion Criteria1
- • Patients that decline to provide informed consent.
Interventions
OTHERQuestionnaires
Participants will complete the survey(s) at the initial visit and every 3 months and/or whenever there is an update in their treatment protocol. Patients may also choose to opt out of the surveys and only consent to primary data collection at the site.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04706754
Related Trials
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
Virtual Agent Feasibility in Oncology Patients (NTT Data)
NCT066820131 location
Empathic Communication Skills (ECS) Training
NCT0545684112 locations
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667100 locations